Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.38 |
| ▸ | PREP | P48147 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6520989 | 0.82 | ALDH1A1 (0.39) | ALDH1A1MAPK1L3MBTL1KMT2A | |
| SCHEMBL6513799 | 0.81 | ALDH1A1 (0.41) | ALDH1A1MAPK1L3MBTL1KMT2A | |
| SCHEMBL6521069 | 0.80 | ALDH1A1 (0.50) | ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A | |
| SCHEMBL9355894 | 0.79 | MDM2 (0.41) | ALDH1A1L3MBTL1ACE2 | |
| SCHEMBL6517062 | 0.78 | ALDH1A1 (0.47) | ALDH1A1MAPK1L3MBTL1SLC15A1CYP3A4 | |
| SCHEMBL6516326 | 0.78 | TSHR (0.45) | ALDH1A1MAPK1CYP2C9CYP2C19PREP | |
| SCHEMBL6520859 | 0.78 | GRIK1 (0.43) | ALDH1A1L3MBTL1KMT2A | |
| SCHEMBL6515208 | 0.77 | TSHR (0.44) | ALDH1A1MAPK1CYP2C9CYP2C19PREP | |
| SCHEMBL6519495 | 0.76 | GRIK1 (0.44) | — | |
| SCHEMBL6519224 | 0.75 | GRIK1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ALDH1A1 1254/4885MAPK1 1916/4885L3MBTL1 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.